cordis.europa.eu/project/rcn/78755_en.html
Preview meta tags from the cordis.europa.eu website.
Linked Hostnames
50- 43 links tocordis.europa.eu
- 4 links toec.europa.eu
- 3 links tocommission.europa.eu
- 1 link toastrazeneca.com
- 1 link toeuropean-union.europa.eu
- 1 link toop.europa.eu
- 1 link toresearch-and-innovation.ec.europa.eu
- 1 link totwitter.com
Thumbnail
Search Engine Appearance
Innovative medicines for europe | INNOMED | Projekt | Fact Sheet | FP6 | CORDIS | European Commission
The discovery and development of new drugs is very costly and attrition rates are high. Initiatives to reduce the rate of attrition during later phases are clearly desirable and if successfully implemented will reduce development costs. The InnoMed proposal addresses the compl...
Bing
Innovative medicines for europe | INNOMED | Projekt | Fact Sheet | FP6 | CORDIS | European Commission
The discovery and development of new drugs is very costly and attrition rates are high. Initiatives to reduce the rate of attrition during later phases are clearly desirable and if successfully implemented will reduce development costs. The InnoMed proposal addresses the compl...
DuckDuckGo
Innovative medicines for europe | INNOMED | Projekt | Fact Sheet | FP6 | CORDIS | European Commission
The discovery and development of new drugs is very costly and attrition rates are high. Initiatives to reduce the rate of attrition during later phases are clearly desirable and if successfully implemented will reduce development costs. The InnoMed proposal addresses the compl...
General Meta Tags
44- titleInnovative medicines for europe | INNOMED | Projekt | Fact Sheet | FP6 | CORDIS | European Commission
- titleLog in
- titleLog in
- titleEnglish
- titleSearch
Open Graph Meta Tags
6- og:descriptionThe discovery and development of new drugs is very costly and attrition rates are high. Initiatives to reduce the rate of attrition during later phases are clearly desirable and if successfully implemented will reduce development costs. The InnoMed proposal addresses the compl...
- og:titleInnovative medicines for europe | INNOMED | Projekt | Fact Sheet | FP6 | CORDIS | European Commission
- og:typearticle
- og:site_nameCORDIS | European Commission
- og:imagehttps://cordis.europa.eu/projects/icons/logo_fp6_big.jpg
Twitter Meta Tags
6- twitter:descriptionThe discovery and development of new drugs is very costly and attrition rates are high. Initiatives to reduce the rate of attrition during later phases are clearly desirable and if successfully implemented will reduce development costs. The InnoMed proposal addresses the compl...
- twitter:titleInnovative medicines for europe | INNOMED | Projekt | Fact Sheet | FP6 | CORDIS | European Commission
- twitter:cardsummary
- twitter:site@CORDIS_EU
- twitter:creator@CORDIS_EU
Link Tags
4- canonicalhttps://cordis.europa.eu/project/id/518170
- icon/favicon.ico
- stylesheet/build/94.b20776ee.css
- stylesheet/build/main.15b95eb3.css
Website Locales
6
dehttps://cordis.europa.eu/project/id/518170/de
enhttps://cordis.europa.eu/project/id/518170
eshttps://cordis.europa.eu/project/id/518170/es
frhttps://cordis.europa.eu/project/id/518170/fr
ithttps://cordis.europa.eu/project/id/518170/it
Emails
1Links
97- http://astrazeneca.com
- http://ww.ciphergen.com
- http://www.arttic.com
- http://www.auth.gr
- http://www.aventis.com